Exelixis
EXEL
378 hedge funds and large institutions have $5.22B invested in Exelixis in 2023 Q2 according to their latest regulatory filings, with 50 funds opening new positions, 108 increasing their positions, 153 reducing their positions, and 33 closing their positions.
777% more call options, than puts
Call options by funds: $84.5M | Put options by funds: $9.63M
52% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 33
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
4% more funds holding
Funds holding: 363 → 378 (+15)
4% less capital invested
Capital invested by funds: $5.45B → $5.22B (-$224M)
2.67% less ownership
Funds ownership: 86.57% → 83.9% (-2.7%)
29% less repeat investments, than reductions
Existing positions increased: 108 | Existing positions reduced: 153
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$64.3M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$58.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$57.2M |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$37.5M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$24.7M |
EXEL Hedge Fund Activity: Q2 2023 in Review
378 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Exelixis (EXEL) for Q2 2023, worth a combined $5.22B — down 4.1% from $5.45B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new EXEL positions and 33 closed out — a net gain of 17 holders — while 108 added to existing stakes and 153 trimmed.
The largest buyer was Farallon Capital Management, adding an estimated $46.1M. The largest seller was Fidelity Investments, cutting an estimated $64.3M.
- 378 institutional investors held Exelixis (EXEL) as of Q2 2023, up from 363 in Q1 2023.
- Funds reported $5.22B of Exelixis stock for Q2 2023, down 4.1% quarter-over-quarter.
- 50 funds opened new Exelixis positions in Q2 2023 and 33 closed out, a net change of +17 holders.
- The largest Exelixis buyer in Q2 2023 was Farallon Capital Management, an estimated $46.1M added.
- The largest Exelixis seller in Q2 2023 was Fidelity Investments, an estimated $64.3M sold.
Based on aggregated 13F filings for Q2 2023.